Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR)

Table 6 Cerebrovascular complications

Follow-upStroke	Total population (n = 257)	SR-group(n = 148)	AF-group(n = 109)	p Value	OR (95% CI)
30 days	3.1% (8/257)	2.7% (4/148)	3.7% (4/109)	0.726	1.37 (0.34–5.61)
3 months	3.1% (8/257)	2.7% (4/148)	3.7% (4/109)	0.726	1.37 (0.34–5.61)
6 months	3.3% (8/241)	2.9% (4/137)	3.8% (4/104)	0.728	1.34 (0.33–5.49)
12 months	5.0% (11*/219)	4.0% (5/124)	6.3% (6/95)	0.537	1.62 (0.48–5.47)

Lists the cerebrovascular complications up to the one-year follow-up. The strokes are shown for the entire patient population and for the two groups during the follow-up period. The parentheses list the number of strokes and the number of patients available for analysis. * Ten ischemic strokes and one hemorrhagic stroke. The occurrence of stroke in the two groups showed no significant difference

ISSN: 1471-2261